Evidence map›Paper›PMID 29021266›Full record

ArticleCirculation. Cardiovascular imaging2017

Imaging to End Points: Cardiovascular Disease Risk Assessment in HIV.

Ahmed M Gharib, Colleen Hadigan

Open access · greenAbstract readEditorialComment
In one paragraph

Article in Circulation. Cardiovascular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ahmed M GharibFrom the Biomedical and Metabolic Imaging Branch, National Institute of Diabetes and Digestive and Kidney Diseases (A.M.G.) and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD.
Colleen HadiganFrom the Biomedical and Metabolic Imaging Branch, National Institute of Diabetes and Digestive and Kidney Diseases (A.M.G.) and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (C.H.), National Institutes of Health, Bethesda, MD. hadiganc@niaid.nih.gov.
National Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 GrantU01AI115711 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI GRINSPOON, STEVEN K., HADIGAN, COLLEEN M · 2015 to 2017
$2.0M
Intramural NIH HHS Z99 AI999999NIAID NIH HHS U01 AI115711
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiovascular DiseasesMyocardial InfarctionHIVHumansPrognosisRisk AssessmentatherosclerosiscocaineEditorialsmyocardial infarctionprevalencerisk factors

Identifiers

PMID29021266
PMCPMC5743232
OpenAlexW2761275868

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.